While this article pertains to an obesity drug and exceptional demand, I thought that we might try to keep things like this in our memory banks, if we think that things might work out kinda similar to Wegovy's "problem" of having a good thing.Consider it some weekend reading, or just take a break and get to it next week. Enjoy your weekend!PHARMACEUTICALSNovo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
KEY POINTS
- Novo Nordisk said Thursday it was cutting the supply of starter doses of its obesity drug Wegovy in the U.S. as it struggles to keep up with surging demand.
- Chief Financial Officer Karsten Munk Knudsen told CNBC that the plans were intended “to safeguard continuity of care” for existing patients in the U.S. market.
- Novo Nordisk reported forecast-beating first-quarter sales Thursday, however shares were down 7% in early deals.
- Forums
- ASX - By Stock
- General OA media and info
While this article pertains to an obesity drug and exceptional...
- There are more pages in this discussion • 419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
-0.010(4.08%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 23.0¢ | $317.0K | 1.319M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49998 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 16000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 49998 | 0.235 |
14 | 192494 | 0.230 |
4 | 110332 | 0.225 |
2 | 18500 | 0.220 |
1 | 10000 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 16000 | 2 |
0.250 | 26709 | 2 |
0.260 | 226992 | 4 |
0.270 | 21950 | 2 |
0.275 | 52444 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
23.5¢ |
  |
Change
-0.010 ( 6.00 %) |
|||
Open | High | Low | Volume | ||
25.0¢ | 26.0¢ | 23.0¢ | 531376 | ||
Last updated 15.58pm 06/05/2024 ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online